Baylor College of Medicine -Methodist Hospital

Houston, Texas 77030

0 studies enrolling now · 9 studies all time

What they study most

Carcinoma, Renal Cell, Prostatic Neoplasms

Studies at this site

• Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer — Stopped early
• Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer — Completed
• Safety Study of RAD001 to Treat Patients With Metastatic Kidney Cancer — Completed
• Efficacy and Safety Study of Xyotax to Treat Prostate Cancer — Completed
• Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer — Stopped early
• Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy — Stopped early
• Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer — Stopped early
• Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer — Stopped early
• Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC — Stopped early